Gut Microbiome in Liver Pathophysiology and Cholestatic Liver Disease

Overview

Journal Liver Res

Date 2022 Mar 31

PMID 35355516

Authors

Shengmin Yan

Xiao-Ming Yin

Affiliations

Soon will be listed here.

Abstract

An increasing amount of evidence has shown critical roles of gut microbiome in host pathophysiology. The gut and the liver are anatomically and physiologically connected. Given the critical role of gut-liver axis in the homeostasis of the liver, gut microbiome interplays with a diverse spectrum of hepatic changes, including steatosis, inflammation, fibrosis, cholestasis, and tumorigenesis. In clinic, cholestasis manifests with fatigue, pruritus, and jaundice, caused by the impairment in bile formation or flow. Studies have shown that the gut microbiome is altered in cholestatic liver disease. In this review, we will explore the interaction between the gut microbiome and the liver with a focus on the alteration and the role of gut microbiome in cholestatic liver disease. We will also discuss the prospect of exploiting the gut microbiome in the development of novel therapies for cholestatic liver disease.

Citing Articles

Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review.

Kanda T, Sasaki-Tanaka R, Kimura N, Abe H, Yoshida T, Hayashi K Int J Mol Sci. 2025; 26(5).

PMID: 40076514 PMC: 11900276. DOI: 10.3390/ijms26051883.

Bile acid metabolism and bile acid receptor signaling in metabolic diseases and therapy.

Chiang J, Fiorucci S Liver Res. 2025; 5(3):103-104.

PMID: 39957844 PMC: 11791837. DOI: 10.1016/j.livres.2021.08.002.

An untargeted comparative metabolomics analysis of infants with and without late-onset breast milk jaundice.

Cui M, Guo Q, Zhao S, Liu X, Yang C, Liu P PLoS One. 2024; 19(8):e0308710.

PMID: 39133689 PMC: 11318923. DOI: 10.1371/journal.pone.0308710.

Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota.

Mendez-Sanchez N, Coronel-Castillo C, Cordova-Gallardo J, Qi X Antibiotics (Basel). 2023; 12(10).

PMID: 37887176 PMC: 10603944. DOI: 10.3390/antibiotics12101475.

Hepatoprotective Properties of Water Kefir: A Traditional Fermented Drink and Its Potential Role.

Aligita W, Singgih M, Sutrisno E, Adnyana I Int J Prev Med. 2023; 14:93.

PMID: 37855014 PMC: 10580206. DOI: 10.4103/ijpvm.ijpvm_29_22.

References

Walter J, Armet A, Finlay B, Shanahan F . Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents. Cell. 2020; 180(2):221-232. DOI: 10.1016/j.cell.2019.12.025. View

Kummen M, Thingholm L, Ruhlemann M, Holm K, Hansen S, Moitinho-Silva L . Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis. Gastroenterology. 2021; 160(5):1784-1798.e0. PMC: 7611822. DOI: 10.1053/j.gastro.2020.12.058. View

Bajaj J, Kakiyama G, Savidge T, Takei H, Kassam Z, Fagan A . Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant. Hepatology. 2018; 68(4):1549-1558. DOI: 10.1002/hep.30037. View

Kang M, Kim H, Kim J, Oh D, Um Y, Seo C . The effect of gut microbiota on drug metabolism. Expert Opin Drug Metab Toxicol. 2013; 9(10):1295-308. DOI: 10.1517/17425255.2013.807798. View

Tedesco D, Thapa M, Chin C, Ge Y, Gong M, Li J . Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease. Gastroenterology. 2018; 154(8):2178-2193. PMC: 5985208. DOI: 10.1053/j.gastro.2018.02.019. View

Ruhlemann M, Liwinski T, Heinsen F, Bang C, Zenouzi R, Kummen M . Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther. 2019; 50(5):580-589. PMC: 6899739. DOI: 10.1111/apt.15375. View

Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M . Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018; 360(6391). PMC: 6407885. DOI: 10.1126/science.aan5931. View

Grander C, Adolph T, Wieser V, Lowe P, Wrzosek L, Gyongyosi B . Recovery of ethanol-induced depletion ameliorates alcoholic liver disease. Gut. 2017; 67(5):891-901. DOI: 10.1136/gutjnl-2016-313432. View

Jiao N, Baker S, Chapa-Rodriguez A, Liu W, Nugent C, Tsompana M . Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2017; 67(10):1881-1891. DOI: 10.1136/gutjnl-2017-314307. View

10.

Schluter J, Peled J, Taylor B, Markey K, Smith M, Taur Y . The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020; 588(7837):303-307. PMC: 7725892. DOI: 10.1038/s41586-020-2971-8. View

11.

Martinez-Guryn K, Hubert N, Frazier K, Urlass S, Musch M, Ojeda P . Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids. Cell Host Microbe. 2018; 23(4):458-469.e5. PMC: 5912695. DOI: 10.1016/j.chom.2018.03.011. View

12.

Quraishi M, Acharjee A, Beggs A, Horniblow R, Tselepis C, Gkoutos G . A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways. J Crohns Colitis. 2020; 14(7):935-947. PMC: 7392170. DOI: 10.1093/ecco-jcc/jjaa021. View

13.

Hirschfield G, Heathcote E, Gershwin M . Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010; 139(5):1481-96. DOI: 10.1053/j.gastro.2010.09.004. View

14.

Li J, Sung C, Lee N, Ni Y, Pihlajamaki J, Panagiotou G . Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci U S A. 2016; 113(9):E1306-15. PMC: 4780612. DOI: 10.1073/pnas.1518189113. View

15.

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M . The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014; 6(263):263ra158. PMC: 4396848. DOI: 10.1126/scitranslmed.3009759. View

16.

Rooks M, Garrett W . Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016; 16(6):341-52. PMC: 5541232. DOI: 10.1038/nri.2016.42. View

17.

Rossen N, Fuentes S, Boonstra K, DHaens G, Heilig H, Zoetendal E . The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. J Crohns Colitis. 2014; 9(4):342-8. DOI: 10.1093/ecco-jcc/jju023. View

18.

Sayin S, Wahlstrom A, Felin J, Jantti S, Marschall H, Bamberg K . Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013; 17(2):225-35. DOI: 10.1016/j.cmet.2013.01.003. View

19.

Kolodziejczyk A, Federici S, Zmora N, Mohapatra G, Dori-Bachash M, Hornstein S . Acute liver failure is regulated by MYC- and microbiome-dependent programs. Nat Med. 2020; 26(12):1899-1911. DOI: 10.1038/s41591-020-1102-2. View

20.

Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L . Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature. 2020; 579(7800):586-591. PMC: 7416516. DOI: 10.1038/s41586-020-2101-7. View